Skip to main content
. 1999 Oct 20;3(6):145–149. doi: 10.1186/cc368

Table 3.

Description of the route of administration for each institutions preferred agent

Agent Administration route n
Histamine-2-antagonist Intermittent IV 63
IV infusion 13
Oral 27
Feeding tube 36
Sucralfate Oral 13
Nasogastric tube 20
Omeprazole Oral 4
Nasogastric tube 4
Enteral tube 2
Other 0

Responders were permitted to check more than one administration route for their institution's preferred agent. IV, intravenous.